Wall Street’s Biggest Midday Movers Show a Market Trading Five Different Narratives at Once
The macro backdrop mattered first. Reuters reported that the Dow, S&P 500 and Nasdaq all finished up more than 1% after President Donald Trump said planned strikes on Iranian power plants had been postponed following productive conversations with Tehran, which sent oil prices down more than 10% and pushed the VIX lower from a two-week high. That created a classic relief rally in cyclical stocks, but it was not the whole story. Some of the session’s most closely watched winners rose because investors also saw company-level developments that could influence long-term earnings power rather than just one day’s risk appetite.
Palantir and Synopsys fit that description best. Reuters reported on March 20 that the Pentagon plans to make Palantir’s Maven system an official program of record, a move that would lock in long-term military adoption and funding for the company’s AI-enabled targeting software. That is a meaningful upgrade from a contract story to a platform-entrenchment story. Synopsys, meanwhile, rallied after Reuters reported that Elliott Investment Management had built a multibillion-dollar stake and sees room for stronger sales and margins. In both cases, investors were responding to the idea that AI demand is still a source of structural upside, whether through defense software or semiconductor design tools.
United Airlines represented a different kind of trade: a high-beta response to oil. Just three days earlier, Reuters reported that United planned to cut about 5% of scheduled capacity in coming quarters because soaring fuel prices linked to the Iran war could keep oil above $100 through 2027 and sharply increase annual fuel costs. On Monday, that pressure suddenly eased as crude retreated and airline stocks surged, with Reuters saying United rose more than 4% during the session. The move underscored how quickly airlines can flip from macro victims to macro beneficiaries when the energy outlook changes.
Flutter’s move was driven by regulation rather than oil or AI. AP reported that Senators Adam Schiff and John Curtis introduced the Prediction Markets are Gambling Act, a bill that would ban sports-related contracts on prediction-market platforms like Kalshi and Polymarket. AP also noted that shares of FanDuel’s parent and DraftKings rose sharply after the announcement. For established online sportsbooks, the logic is straightforward: prediction markets have become an increasingly serious competitive threat because they can reach users nationally under a different regulatory framework. Any sign that lawmakers may curb that channel is being read as a potential win for incumbent operators’ pricing power and customer economics.
Insmed’s rally came from the most traditional stock-moving catalyst of all: clinical data. The company announced positive topline results from its Phase 3b ENCORE study of ARIKAYCE in patients with MAC lung disease, saying the study met its primary endpoint and all multiplicity-controlled secondary culture-conversion endpoints. The press release showed statistically significant improvement in respiratory symptom score and markedly higher culture-conversion rates versus placebo, and Insmed said it plans to file a supplemental NDA with the FDA in the second half of 2026. In a market dominated by geopolitics and rates, Insmed stood out as a reminder that clean execution on a drug program can still cut through everything else.
